These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19995331)

  • 1. Interaction between clopidogrel and proton pump inhibitors: hypothesis to explain multifactorial CYP2C19 inhibition.
    Zhang H; Ragueneau-Majlessi I; Levy RH
    Drug Metab Lett; 2009 Dec; 3(4):287-9. PubMed ID: 19995331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes.
    Furuta T; Iwaki T; Umemura K
    Br J Clin Pharmacol; 2010 Sep; 70(3):383-92. PubMed ID: 20716239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clopidogrel--proton pump inhibitors drug interaction: implications to clinical practice].
    Fontes-Carvalho R; Albuquerque A
    Rev Port Cardiol; 2010 Oct; 29(10):1555-67. PubMed ID: 21268429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clopidogrel and proton pump inhibitors: insufficient evidence of interaction].
    Hunfeld NG; Valkhoff VE; Touw DJ; Sturkenboom MC; Kuipers EJ
    Ned Tijdschr Geneeskd; 2011; 155(28):A2404. PubMed ID: 21771376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of rabeprazole on the antiplatelet effects and pharmacokinetics of clopidogrel in healthy volunteers.
    Funck-Brentano C; Szymezak J; Steichen O; Ducint D; Molimard M; Remones V; Azizi M; Gaussem P
    Arch Cardiovasc Dis; 2013 Dec; 106(12):661-71. PubMed ID: 24246616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPI interactions with clopidogrel revisited.
    Med Lett Drugs Ther; 2009 Feb; 51(1306):13-4. PubMed ID: 19229161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug interaction between clopidogrel and proton pump inhibitors.
    Khalique SC; Cheng-Lai A
    Cardiol Rev; 2009; 17(4):198-200. PubMed ID: 19525682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-drug interaction between clopidogrel and the proton pump inhibitors.
    Norgard NB; Mathews KD; Wall GC
    Ann Pharmacother; 2009 Jul; 43(7):1266-74. PubMed ID: 19470853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between clopidogrel and proton pump inhibitors: a review of evidence.
    Muñoz-Esparza C; Jover E; Hernández-Romero D; Saura D; Valdés M; Lip GY; Marín F
    Curr Med Chem; 2011; 18(16):2386-400. PubMed ID: 21568918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution?
    Kenngott S; Olze R; Kollmer M; Bottheim H; Laner A; Holinski-Feder E; Gross M
    Eur J Med Res; 2010 May; 15(5):220-4. PubMed ID: 20562062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors, genetic polymorphisms and response to clopidogrel therapy.
    Fernando H; Dart AM; Peter K; Shaw JA
    Thromb Haemost; 2011 Jun; 105(6):933-44. PubMed ID: 21544314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of interactions between clopidogrel and proton pump inhibitors].
    Kubica A; Koziński M; Grześk G; Goch A
    Kardiol Pol; 2011; 69(6):610-6. PubMed ID: 21678305
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of an increased clopidogrel maintenance dose or lansoprazole co-administration on the antiplatelet response to clopidogrel in CYP2C19-genotyped healthy subjects.
    Hulot JS; Wuerzner G; Bachelot-Loza C; Azizi M; Blanchard A; Peyrard S; Funck-Brentano C; Gaussem P
    J Thromb Haemost; 2010 Mar; 8(3):610-3. PubMed ID: 20040040
    [No Abstract]   [Full Text] [Related]  

  • 14. Does CYP2C19 inhibition lead to clopidogrel thrombogenicity?
    Cohen MJ
    Med Hypotheses; 2011 Sep; 77(3):448-50. PubMed ID: 21719206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of proton pump inhibitor omeprazole on the antiplatelet effect of clopidogrel in individuals with various CYP2C19*2 genotypes].
    Lu FM; Tong ZL; Mao YM; Wu DY; Xu J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Aug; 29(4):478-81. PubMed ID: 22875511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite.
    Kazui M; Nishiya Y; Ishizuka T; Hagihara K; Farid NA; Okazaki O; Ikeda T; Kurihara A
    Drug Metab Dispos; 2010 Jan; 38(1):92-9. PubMed ID: 19812348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors and clopidogrel: an association to avoid?
    D'Ugo E; Rossi S; De Caterina R
    Intern Emerg Med; 2014 Feb; 9(1):11-22. PubMed ID: 24030523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians.
    Tran M; Tafreshi J; Pai RG
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):326-37. PubMed ID: 20938037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of proton pump inhibitors and famotidine on the clopidogrel metabolic activation by recombinant CYP2B6, CYP2C19 and CYP3A4.
    Ohbuchi M; Noguchi K; Kawamura A; Usui T
    Xenobiotica; 2012 Jul; 42(7):633-40. PubMed ID: 22313038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials.
    Dunn SP; Steinhubl SR; Bauer D; Charnigo RJ; Berger PB; Topol EJ
    J Am Heart Assoc; 2013 Jan; 2(1):e004564. PubMed ID: 23525436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.